| Weiyu Lu, DO | |
|
34 S Railroad St, Tamaqua, PA 18252-1927 | |
| (570) 645-1950 | |
| Not Available |
| Full Name | Weiyu Lu |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 34 S Railroad St, Tamaqua, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962255760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OT023210 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Weiyu Lu, DO 34 S Railroad St, Tamaqua, PA 18252-1927 Ph: () - | Weiyu Lu, DO 34 S Railroad St, Tamaqua, PA 18252-1927 Ph: (570) 645-1950 |
News Archive
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported promising in vitro data for IDX320, an HCV protease inhibitor, demonstrating potent and selective antiviral activity in multiple genotypes, or strains, of the virus.
The benefits of intravenous tissue plasminogen activator outweigh the risks in acute stroke patients treated within 4.5 hours of symptom onset, reports the Stroke Thrombolysis Trialists' Collaboration.
Discovery Laboratories, Inc., announced today that, on November 30, 2010, the Company received a Staff Determination letter from The Nasdaq Stock Market indicating that the Company has not established compliance with Nasdaq Listing Rule 5550(a)(2) ("Minimum Bid Price Rule") because the Company's common stock did not maintain a minimum closing bid price of $1.00 per share over a period of 10 consecutive business days ending on or prior to November 29, 2010.
A new study from the Oklahoma Medical Research Foundation (OMRF) shows that immunization could offer a way to blunt or even prevent the deadly, memory-robbing disease.
Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have delineated novel molecular interactions affecting the activity of the TGF-β pathway, a key cancer pathway in humans affecting cancer progression.
› Verified 1 days ago
Dr. Thomas J Dirnberger, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 30 Short St, Tamaqua, PA 18252 Phone: 570-386-1288 Fax: 570-386-4724 | |
Bridget Marie Smith, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S Railroad St, Tamaqua, PA 18252 Phone: 570-645-1950 | |
Steven Picozzo, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S. Railroad Street, Tamaqua, PA 18252 Phone: 570-645-1950 | |
Dr. Catherine Wang, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S Railroad St, Tamaqua, PA 18252 Phone: 570-645-1950 Fax: 570-645-1955 | |
Biju Babu, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S Railroad St, Tamaqua, PA 18252 Phone: 570-645-1950 | |
Dr. Gayathri Gurumurthy, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S Railroad St, Tamaqua, PA 18252 Phone: 570-645-1950 Fax: 570-645-1955 | |
Benjamin Peter Wenger, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S Railroad St, Tamaqua, PA 18252 Phone: 570-645-1950 Fax: 570-645-1955 |